Skip to main content
BrainCited

Ginkgo biloba 관련 Cerebrovascular Health

B

Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dginkgo\u002Dbiloba\u0026condition\u003Dcerebrovascular\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.

Key Study Findings

Review
[Treatment of mild cognitive impairment: value of citicoline].
Dose: None vs: None Outcome: cognitive function improvement in mild cognitive impairment 효과: None None

대상 집단: elderly patients with mild cognitive impairment or chronic brain diseases

Review
Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines.
Dose: None vs: None Outcome: ASD symptom management 효과: None None

대상 집단: Children with autism spectrum disorder

Other
Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 …
Dose: None vs: BCAS model mice without GBE50 Outcome: Cognitive impairment and white matter lesions 효과: None None

대상 집단: BCAS cerebral small vessel disease mouse model

Meta-Analysis n=22347
Therapeutic strategies in vascular cognitive impairment: A systematic review and meta-analysis.
Dose: None vs: Various controls Outcome: Cognition and functional outcomes in VCI 효과: Ginkgo biloba: Cohen's d 0.83 [0.00-1.67] cognitio None

대상 집단: Patients with vascular cognitive impairment (173 trials)

Other 10 weeks
Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of …
Dose: None vs: Untreated APP/PS1 mice Outcome: Cognitive performance in behavioral tests 효과: None None

대상 집단: APP/PS1 transgenic Alzheimer's disease mouse model

In Vitro
Ginkgo biloba extract mediates HT22 cell proliferation and migration after oxygen-glucose deprivation/reoxygenation via regulating RhoA-ROCK2 …
Dose: None vs: OGD/R model vs control in HT22 cells Outcome: Cell proliferation and migration via RhoA-ROCK2 효과: None None

대상 집단: HT22 mouse hippocampal neurons under OGD/R

Key Statistics

12

연구

2000

참여자

Positive

B

등급

Referenced Papers

Revista de neurologia None 3 인용
Acta pharmaceutica Sinica. … 2024 33 인용
The Senior care … 2021 2 인용
Biomedicine & pharmacotherapy … 2020 427 인용
The Practitioner 2010
Annals of clinical … 2003 47 인용
American family physician 2003
The Medical clinics … 2002 59 인용
Archives of physical … 2000 408 인용
Current opinion in … 1998 30 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones

상한량: 600 mg/day (doses above show no additional benefit)

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Positive 22347
None 10 weeks Positive --
None -- Positive --
None -- Positive --
None -- Positive --

권장 복용 시간: With meals; may require 4-6 weeks for full effects

Safety & Side Effects

보고된 부작용

  • Headache
  • Gastrointestinal upset
  • Dizziness
  • Allergic skin reactions (rare)
  • Increased bleeding risk

알려진 상호작용

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Anticonvulsants (may reduce seizure threshold)
  • SSRIs (serotonin syndrome risk, rare)
  • CYP3A4 substrates (may affect drug metabolism)

일일 최대 섭취 허용량: 600 mg/day (doses above show no additional benefit)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Ginkgo biloba help with Cerebrovascular Health?
Based on 12 studies with 2,000 participants, there is moderate evidence from clinical studies that Ginkgo biloba may support Cerebrovascular Health management. Our evidence grade is B (Good Evidence).
How much Ginkgo biloba should I take for Cerebrovascular Health?
Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ginkgo biloba?
Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ginkgo biloba and Cerebrovascular Health?
We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

관련 다른 성분: Cerebrovascular Health

Ginkgo biloba 다른 건강 상태에 대한 근거

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.